BofA/Merrill Lynch analyst Derik Brulin downgraded Hologic (NASDAQ: HOLX) from Buy to Neutral ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change Downgrades Hot Downgrades